1. Introduction {#sec1}
===============

IL-8 is a potent activator for eosinophil chemotaxis in vitro and in vivo \[[@B1]\]. IL-8 also possesses a clear role in eosinophil chemotaxis in allergic respiratory diseases \[[@B3], [@B4]\]. On the other hand, IL-15 effect on human eosinophil is through inhibition of the spontaneous apoptosis via the autocrine production of GM-CSF and thus may perpetuate allergic inflammation by prolonged eosinophil survival \[[@B5]\]. Nonetheless, the role of IL-15 in the pathophysiology of allergic airways diseases is still in its infancy and remains a controversial issue \[[@B6]--[@B10]\].

NK cells activation plays a pivotal role in viruses and tumor lyses \[[@B11]\]; however, they also produce cytokines and thus are thought to play a proinflammatory role \[[@B12]\]. The secretagogue activity of NK cells includes IFN-*γ*, IL-10, TNF-*α*, MIP-1, MIP-1*β*, and GM-CSF. These cytokines are augmented by IL-15, a cytokine produced by activated monocytes/macrophages \[[@B13], [@B14]\]. Some investigators demonstrated the ability of NK cells to differentiate in the presence of IL-4 into NK cell subsets secreting distinct cytokines patterns similar to T~H2~ profile such as IL-5 and IL-13 \[[@B15], [@B16]\]. A more recent study demonstrated the existence of type 2 cytokine-secreting NK cells in AR and showed increased number and enhanced cytotoxicity of NK cells \[[@B17]\]. This highlights a novel role for NK cells in allergic diseases. Nonetheless, whether NK cells are able to attract eosinophils through IL-8 secretion is not known.

Increasing evidence supports a novel immunoregulatory role for vitamin D in allergic diseases such as asthma and AR \[[@B18], [@B19]\]. The ability of vitamin D to reduce cytokines from inflammatory cells is also well acknowledged. Therefore, the therapeutic potential of vitamin D as an anti-inflammatory agent in allergic diseases remains a subject of interest.

Herein, we show a novel crosstalk between human NK cell and eosinophil recruitment through IL-15/IL-8 axis. Results are discussed in relation to the possible novel therapeutic effect of vitamin D in downregulating this inflammatory event, and the possible role for NK cells in the pathophysiology of AR.

2. Materials and Methods {#sec2}
========================

2.1. Cell Preparation {#sec2.1}
---------------------

Eosinophils and NK cells were isolated by Percoll (66%) solution. NK cells were isolated from buffy coats to obtain large amount of cells for culture purposes, and eosinophils were freshly isolated from the peripheral blood of sixteen AR patients sensitized to different aeroallergens that were confirmed by skin tests and/or radioallergosorbent test (RAST). Eosinophils and NK cells were further purified by negative selection immunomagnetic cell separation (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany), using anti-CD16 magnetic beads for eosinophils purification, and a cocktail of biotin-conjugated antibodies against lineage-specific antigens and a cocktail of microbeads (NK Cell Isolation Kit-human, Miltenyi Biotec, Bergisch Gladbach, Germany) for NK (CD56+ve CD3-ve) cells purification. Cells purity was \>96% for both cell types. Cells viability was always \>98% as judged by trypan blue.

2.2. Cell Culture {#sec2.2}
-----------------

NK cells (1 × 10^6^ cells) were incubated in the presence or absence of 1 ng/mL IL-15 (R&D Systems; Minneapolis, MN), 10^−6^ M concentration of vitamin D~3~ (Cayman Chemical), 10^−5^ M concentration of H-89 Dihydrochloride (VWR-CALBIOCHEM), a PKA inhibitor, 10^−5^ M concentration of Bisindolylmaleimide (VWR-CALBIOCHEM), a PKC inhibitor, 10^−5^ M concentration of SB203580 (VWR-CALBIOCHEM), a P38 MAP-Kinase inhibitor, or 1 *μ*M concentration of Genistein (Sigma), a tyrosine kinase inhibitor, at 37°C-5% CO~2~ with 1 mL RPMI-1640 supplemented with 100 U penicillin/mL and 100 *μ*g streptomycin/mL (Lonza, Verviers, Belgium), 10% of inactivated fetal calf serum (Lonza) in 24 wells plate (BD biosciences). After 72 h incubation period, supernatants were carefully collected and analysed for their eosinophilotactic activity or IL-8 content.

As for the measurement of IL-8 content induced by peripheral blood NK cells from AR patients before and after nasal challenge, peripheral blood NK cells were purified from additional four AR patients to house dust mite (HDM). After obtaining the patients consent, 30 mls of peripheral blood was obtained before and 6 hours after nasal challenge with HDM allergen. Purified NK cells at the concentration of 3 × 10^6^ cells/mL were incubated in the culture medium for 72 hrs. Supernatants were collected and the amount of IL-8 was measured by ELISA.

2.3. Chemotaxis Assays {#sec2.3}
----------------------

Chemotaxis assays were performed in triplicate in a 48-well microchemotaxis Boyden chambers incubated in 5% CO~2~ at 37°C for 90 min. Aliquots of 29 *μ*L of the NK supernatant were placed in the lower wells and 50 *μ*L of eosinophils suspension (10^6^ cells/mL) were placed in the upper wells. The two chambers were separated by a 5.0 *μ*m pore polycarbonate membrane (Nuclepore, Whatman, Middlesex, UK). Migrated cells adherent to the lower surface were counted in 5 selected high power fields/well under a light microscope (5 hpf; X400). As for blocking experiments, NK supernatants were preincubated for 1 h and during the chemotaxis assay, with different doses (10^−8^--10^−6^ g/mL) of the monoclonal anti-IL-8Ab that neutralizes the biological activity of IL-8 (R&D systems; Minneapolis. MN).

2.4. Enzyme-Linked Immunosorbant Assay (ELISA) {#sec2.4}
----------------------------------------------

The content of IL-8 was measured in supernatants of NK cells using human IL-8 cytoset Kit (Invitrogen corporation, USA) according to the manufacturers\' recommendations.

2.5. Statistical Analysis {#sec2.5}
-------------------------

Statistical significance was performed by paired *t*-test. Values of *P* \< 0.05 were considered significant.

3. Results {#sec3}
==========

3.1. NK Cells Supernatants-Induced Eosinophil Chemotaxis {#sec3.1}
--------------------------------------------------------

NK cells supernatants induced chemotaxis of eosinophils from AR patients ([Figure 1](#fig1){ref-type="fig"}). NK cells treatment with the optimal dose of 1 ng/mL IL-15 during the culture period resulted in significant augmentation of NK cells supernatant-induced eosinophil chemotaxis from AR patients to almost 3-fold chemotaxis index. These results indicate a novel autocrine activity for NK cells in recruiting eosinophils and highlight a novel role for IL-15 in up-regulating this effect.

3.2. Blocking Activity of Anti-IL8 Ab {#sec3.2}
-------------------------------------

[Figure 2](#fig2){ref-type="fig"} shows that eosinophil chemotaxis of AR patients against NK supernatant of cells treated by IL-15 was significantly blocked by anti-IL-8 Ab. The blocking activity was in a dose-dependent fashion, but was not completely blocked to the control level. These results indicate that NK cells stimulated by IL-15 secrete eosinophilotactic chemokines that include at least in part IL-8 among others. To confirm this, we next measured by ELISA the amount of IL-8 spontaneously secreted by NK cells, and the modulatory effects of IL-15 and vitamin D~3~ on IL-8 secretion.

3.3. Modulation of the Amount of Secreted IL-8 in NK Cells Supernatant by IL-15 and Vitamin D~3~ {#sec3.3}
------------------------------------------------------------------------------------------------

We tested the amount of IL-8 secreted by NK cells after 72 h culture period in the presence and absence of the optimal doses of IL-15 or vitamin D~3~. As can be seen in [Table 1](#tab1){ref-type="table"}, cultured NK cells for 72 h secreted IL-8. The amount of recovered IL-8 was increased from 88.64 ± 21.5 to 178.9 ± 23.6 Pg/mL and was significantly reduced by vitamin D~3~ to 59.2 ± 16.3 Pg/mL. These results indicate the ability of IL-15 to upregulate the IL-8 secretagogue activity by NK cells, and the ability of vitamin D~3~ to significantly inhibit the IL-8 secretagogue activity of NK cells. Furthermore, it confirms the contribution of IL-8 to the eosinophilotactic cytokines secreted by NK cells.

However, to gain insight into the possible signal pathway involved in NK cell induced-IL-8 modulation by IL-15 and vitamin D~3~, we treated NK cells with different kinases inhibitors during the culture period. H-89 Dihydrochloride, Bisindo-lylmaleimide, or Genistein did not modulate the amount of IL-8 secreted by NK cells (data not shown). However, as can be seen in [Table 1](#tab1){ref-type="table"}, IL-8 secretion by NK cells was sensitive to SB203580 and resulted in reduction of IL-8 to 15 ± 0.5 Pg/mL. Similarly, the augmentation of IL-8 secretion by IL-15 was reduced by SB203580 to 54.75 ± 5.7. These results may indicate the involvement of P38 MAP-Kinase pathway in the signal transduction of IL-8 secretion by NK cells.

3.4. Modulation of the Amount of Secreted IL-8 in NK Cells Supernatant from AR Patients after Nasal Challenge {#sec3.4}
-------------------------------------------------------------------------------------------------------------

Finally to further correlate our results to the pathophysiology of AR, we challenged AR patients to HDM with HDM allergen. NK cells purification before and at 6 h postchallenge were cultured for 72 h. Collected supernatants were checked by ELISA for the amount of IL-8 recovered. As demonstrated in [Figure 3](#fig3){ref-type="fig"}, after nasal challenge NK cells secreted a significantly higher amount of IL-8. This result indicates the importance of NK cells as a source for IL-8 in the pathophysiology of AR.

4. Discussion {#sec4}
=============

In the current communication, we demonstrated a novel crosstalk between NK cells and eosinophils via IL-15/IL-8 axis. This may indicate a role for IL-15 in the pathophysiology of allergic rhinitis late-phase reaction and the promotion of eosinophilic inflammation.

In AR disease, the mixed in vivo milieu of T~H2~ cytokines especially induced after allergen exposure prime eosinophils. This makes them exhibit distinct phenotype and exaggerated responses to chemokines such as IL-8 \[[@B20]\]. Herein, we show that nasal allergen challenge of AR patients also primes NK cells to secrete larger amounts of IL-8. Further, the ability of NK cells to secrete IL-8 in their supernatants that contributed to the attraction of eosinophils from AR patients may provide a further explanation to eosinophil recruitment in AR.

IL-15 prolongs eosinophil survival and thus acts as a proeosinophilic inflammatory mediator \[[@B5]\]. In the current study, IL-15 demonstrated a further novel indirect role in helping eosinophil recruitment, at least in part through secretion of IL-8 from resting NK cells.

Vitamin D binds to its nuclear receptor, the vitamin D receptor (VDR) through which it signals in its target cells. We demonstrated a significant inhibition of IL-8 by NK cells in the presence of Vitamin D~3~. This is consistent with an earlier study that demonstrated that vitamin D~3~ repressed IL-8 promoter activity induced by TNF-*α* in human melanoma cell line by 50% compared to 30% inhibition by dexamethasone, as well as TNF-*α*-induced IL-8 release and IL-8 mRNA level \[[@B21]\].

The fact that IL-8 secretion by NK cells was sensitive to P38 MAP-Kinase inhibition may indicate that IL-15 and vitamin D~3~ modulated IL-8 autocrine activity of NK cells through the same pathway. It is then reasonable to assume that IL-15 may induce IL-8 secretion by NK cells through stimulation of P38 MAP-kinase activity and that vitamin D~3~ reduces IL-8 secretion from NK cells through blocking effect on the P38 MAP-Kinase pathway. Nonetheless, further studies are needed to prove or disprove this hypothesis. In conclusion, our results may indicate the following:

1.  a novel role for NK cells in the pathophysiology of AR through recruiting eosinophils,

2.  a novel modulatory role for IL-15 in inducing eosinophils chemotaxis from AR patients through the NK cells secretagogue activity,

3.  identifying IL-8 as an important cytokine that contributes to the eosinophilotactic agents secreted by NK cells,

4.  indicating that vitamin D~3~ may be an effective therapeutic modality.

Our results open channels for other researchers to further elaborate on the exact mechanism(s) involved in NK-induced IL-8 modulation by IL-15 and vitamin D~3~ and P38 MAP-Kinase inhibition.
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![Eosinophilotactic activity of supernatants of resting NK cells versus supernatants of NK cells stimulated with IL-15. Results are the mean ± SEM of 10 independent experiments performed in triplicate. Asterisks indicate *P* \< 0.05 by paired *t*-test.](MI2011-373589.001){#fig1}
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![Amount of IL-8 secreted by NK cells of AR patients sensitized to HDM before and 6 h after nasal challenge with HDM allergen. Results are the mean ± SEM of 4 independent experiments. Asterisks indicate *P* \< 0.05 by paired *t*-test.](MI2011-373589.003){#fig3}

###### 

Amount of IL-8 recovered in supernatants of NK cells after 72 h culture period.

  Stimulant                              IL-8 (Pg/mL) in NK cells supernatants
  -------------------------------------- ---------------------------------------
  RPMI                                   88.6 ± 21.5
  IL-15 (1 ng/mL)                        178.9 ± 23.6
  Vit D~3~ (10--6 M)                     59.2 ± 16.3\*\*\*
  SB203580 (10--5 M)                     15 ± 0.5\*\*\*
  IL-15 (1 ng/mL) + SB203580 (10--5 M)   54.75\*\*\*

Results are ±SEM of 4--8 independent experiments. Asterisks indicate *P* \< 0.05 by paired *t*-test.
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